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Abstract 
Background 
Multi-compartment compliance aids (MCAs) are repackaging systems for solid dosage 
form medicines. Acknowledging the lack of evidence that MCAs improve adherence or 
clinical outcomes, the Royal Pharmaceutical Society has expressed concern that MCAs 
have ‘become regarded as a panacea for medicines use’.  
Objectives 
To determine the behaviors and experiences of the community pharmacy team around 
MCA provision. 
Methods 
A cross-sectional survey was conducted in 26 community pharmacies in the north east of 
Scotland. Survey items were grouped into: current activities in the provision of MCAs; 
potential influences on these activities; reports of patient experiences; and 
demographics. Data were analysed using descriptive and inferential statistics, and 
content analysis of responses to open questions. Principal component analysis (PCA) was 
performed on the items of potential influences on activities. 
Results  
Data were collected from 136 community team members (median 4, range1-10 per 
pharmacy; 32.3% pharmacists). All were involved in some aspect of MCA provision and 
within the same pharmacy, several different staff positions were commonly involved in 
the same activity. PCA gave seven components; the lowest scores were obtained for the 
component of ‘others expecting me to provide MCAs’. Participants agreed that GPs, 
patients and their families, and carers expected them to provide MCAs. Positive 
experiences of MCA provision were in themes of promoting patient adherence, reducing 
patient stress and enhancing patient monitoring. Further negative experiences were in of 
lack of shared patient decision making, worsening adherence and generation of 
medicines waste, and dealing with changing medicines. MCAs were not always 
considered to be the most appropriate solution.  
Conclusion 
While community pharmacy teams value MCAs, there may be issues around staff 
assignment to particular roles, expectations from others and reports of negative patient 
experiences. A systematic approach to MCA provision and monitoring involving the 
multidisciplinary health and social care team is warranted.  
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Introduction 
Multi-compartment compliance aids (MCAs) are repackaging systems for solid dosage 
form medicines, such as tablets and capsules, where the medicines are removed from 
manufacturer’s original packaging and repackaged into the MCA.1 While these are 
advocated widely as a solution to non-adherence, the Royal Pharmaceutical Society of 
Great Britain, the professional leadership body, states that pharmacy supplied MCAs 
have ‘become regarded as a panacea for medicines use and often integrated into 
practice and service policy without giving due consideration to the alternatives’.1 
Despite their use, there is a dearth of evidence that MCAs improve medicines adherence. 
A systematic review of the effectiveness of reminder packaging for improving medicines 
adherence was reported by Mahtani et al. in 2011. Of the 12 randomised controlled trials 
comparing MCAs to no device, findings demonstrated scant evidence of impact on 
medicines adherence or any clinical outcomes studied.2 A further systematic review 
reported by Watson et al. in 2016 on the evidence for the efficacy, safety and costs 
relating to MCA use derived from 17 studies also concluded that the evidence was 
limited.3 In addition, they noted that studies were generally of poor quality and at high 
risk of bias. Both systematic reviews highlighted the difficulties of obtaining valid and 
reliable measures of adherence in those using MCAs. MCA use in older people has also 
been associated with lower patient knowledge of their medicines, an effect thought due 
to patients not recognising the different medicines within the MCA.4  
Qualitative studies have also highlighted concerns over MCA use. Nunney et al. 
conducted qualitative interviews with older people living independently in England and 
an unrelated sample of health professionals involved in MCA provision.5 Older people had 
mixed views on whether MCAs helped or hindered in maintaining independence and 
control over medicines. None of the older people reported that the MCA had aided 
adherence. Health professionals voiced that MCAs were often initiated without any 
systematic patient assessment. More recently, MacLure et al. reported a case study 
methodology of older residents of very sheltered housing in the north east of Scotland. 
Data were gathered from multiple perspectives of residents, carers and health 
professionals. While MCAs were valued by some, particularly the potential to improve 
medicines adherence, patient safety and independent living, the overwhelming finding 
was the absence of a clearly defined, effective and efficient approach to MCA provision 
and review.6  
Several studies have also demonstrated that MCA use could perpetuate potentially 
inappropriate prescribing, which is perhaps due to the lack of clinical review of 
prescribed medicines prior to commencing the MCA. Two pharmacoepidemiology studies 
based on data derived from prescribing databases in Sweden demonstrated that MCA 
use was associated with increased potentially inappropriate prescribing and potentially 
clinically significant drug-drug interactions.7,8 Further Swedish data were reported by 
Belfrage et al. in a comparison of medicines related issues observed in 100 MCA patients 
to those in 100 non-MCA patients. Findings highlighted that MCA patients had a mean of 
an additional 0.77 potentially inappropriate medicines.9 More recently, Counter et al. 
provided further evidence that MCAs perpetuate potentially inappropriate prescribing. 
Data were collected from pharmacies in the north east of Scotland supplying up to 136 
MCAs per week to 2060 non-care home residents. A total of 1977 potentially 
inappropriate medicines were identified affecting 58% of patients, a quarter of whom 
were prescribed ten or more medicines and just under half had potentially clinically 
significant drug-drug interactions.10 
There are other related issues which may compromise patient safety through the use of 
MCAs. The preparation of MCAs requires that medicines are removed from their original 
packaging and placed either manually or automatically into the individual compartments 
of the MCA, increasing the opportunity for error.11 Carruthers et al. audited MCA 
dispensing in Australia, reporting errors prevalent in 4.3% of MCAs, the most common 
being omitted medicines, supply of ceased medicines, wrong strength dispensed or 
incorrect dosage instructions.12  
It is therefore evident that there is a need to review the patient care pathway leading to 
the provision and review of MCAs. Prior to developing such a pathway, the perspectives 
of those involved in any aspect of MCA provision should be described and understood. 
While studies have reported the perspectives of patients, health professionals and formal 
carers, the voices of the entire community pharmacy team are yet to be heard. The aim 
of the study was to determine the behaviors and experiences of the community 
pharmacy team around MCA provision.  
 
  
Methods 
Design 
This study was a cross-sectional survey using a researcher administered data collection 
tool.  
 
Setting 
The study took place within community pharmacies in one city in the north east of 
Scotland. 
 
Recruitment 
An email was sent to all pharmacies in the city (n=51) by a primary care lead 
pharmacist to raise awareness of the study and that during November and December 
2015, researchers would be visiting pharmacies in Aberdeen to collect data from a 
convenience sample of available pharmacy staff. A participant information leaflet was 
attached to the email outlining: the purpose of the study; what was involved; likely 
benefits; and the confidentiality and anonymity of data. Potential participants were all 
members of the community pharmacy team who played a role on MCA provision. These 
were defined as pharmacists, pre-registration pharmacists, registered pharmacy 
technicians (accredited checking), registered pharmacy technicians, dispensing 
assistants, medicines counter assistants and delivery drivers. Prior to collecting data, the 
researchers confirmed that the information leaflet had been read and answered any 
questions. Participation in data collection was considered to be an indication of consent.  
 
Data collection tool development and testing 
A structured data collection tool was developed, and reviewed for face and content 
validity by pharmacist academics, and community and primary care pharmacists. Minor 
changes were made to the wording of several items.  
Items were grouped into sections of: current activities in the provision of MCAs; 
potential influences on these activities; reports of patient experiences; and 
demographics. A structured list was used to capture each participant’s involvement in 
various activities related to MCA provision (12 items, all answered yes, no) comprising: 
dispensing; completion of any documentation; assessment of patient suitability for MCA; 
clinical checking of MCA prescriptions; final accuracy checking of MCA dispensing; 
handing over of MCAs to patients or their representatives; delivery to patients’ homes; 
collection of obsolete MCAs; liaising with GP surgeries over ordering; liaising with GP 
surgeries over any queries; liaising with the patients or their representatives; and 
monitoring benefit of MCA provision to patients.  
These items were then repeated in relation to who the pharmacy staff member believed 
should ideally fulfil that role.  
Items related to influences on behavior (32 items), answered on 5-point Likert scales, 
were based on the 14 domains of the Theoretical Domains Framework (TDF). The TDF 
includes constructs from 33 behavior change theories, and proposes that determinants 
of behavior are clustered into 14 domains of: knowledge; skills; social/professional role 
and identity; beliefs about capabilities; optimism; beliefs about consequences; 
reinforcement; intentions; goals; memory, attention and decision processes; 
environmental context and resources; social influences; emotions; and behavioral 
regulation.13 The TDF Determinants of Implementation Behavior Questionnaire was used 
as a basis for the development of the individual items.14 
Three free text response items were included to collect experiential data on: specific 
examples of patients (anonymised) who had derived benefits from having an MCA; 
examples of those where MCA provision had not been successful; and any other relevant 
comments.  
Person and practice demographics (6 items, all closed questions) were: age; sex; 
position title; number of years in current position; personal life experience of MCAs (e.g. 
provided to family members or friends); and pharmacy type. 
Prior to the study, the data collection processes and tool were piloted in one community 
pharmacy and as no major amendments were required, pilot data were included in the 
final study dataset.  
 
Data collection 
Data were collected in each pharmacy by trained final year undergraduate pharmacy 
students. Following confirmed willingness of the pharmacy team member to participate, 
the student read each item on the data collection tool and entered their responses. It 
was considered that this approach to recruitment and data collection was likely to 
achieve a higher participation rate than would be obtained via self-completion, as 
demonstrated by others.15 Anonymised data collection was undertaken in a private area 
of the pharmacy to avoid the participant being overheard.  
 
 
Analysis 
Data were entered into SPSS version 21.0, with a data entry reliability (all entries double 
checked) check performed on all entries, and analysed using descriptive and inferential 
statistics. The 5-point Likert scale items relating to TDF behavioral determinants were 
subjected to principal components analysis (PCA) – a statistical technique used to reduce 
a large number of items or variables to a smaller, more manageable number of 
components.16 Data suitability for PCA was tested via determination of the correlation 
matrix for co-efficients (≥0.3), the Kaiser-Meyer-Olkin measure of sampling adequacy 
(≥0.6) and Bartlett’s test of sphericity (≤0.05). The number of components was 
determined via Eigenvalues >1 and visual inspection of the scree plot. Oblique (Promax) 
rotation was used to aid the interpretation of the components as, from a theoretical 
perspective, there was reason to assume that selected attitudinal items were correlated; 
missing data were excluded pairwise.16 Where items cross loaded onto more than one 
component, the item was captured within the component of highest loading Internal 
consistencies of the resulting component(s) were tested using Cronbach’s alpha, aiming 
for >0.60 as desirable for psychometric scales.17 Total component scores were obtained 
by assigning scores of 1 (strongly disagree) to 5 (strongly agree) to each of the Likert 
statement responses, with negatively worded items being reverse scored, and 
generating a summed score for each component. Differences in total scores between 
groups (position [pharmacist v non-pharmacist], years of experience [≤5 years v >5 
years], type of pharmacy [small independent, small multiple, large multiple], personal 
experience of MCA outwith work [yes v no]) in relation to component scores were tested 
using Mann-Whitney U test (2 groups) or Kruskal-Wallis (>2 groups).  
Responses to the open questions were analysed thematically using a content analysis 
approach.18 Coding was undertaken by two independent researchers, with a third 
consulted when non-consensus arose. 
 
Ethics 
This study was approved by the Ethical Review Panel of the School of Pharmacy and Life 
Sciences at Robert Gordon University, UK; the North of Scotland Research Ethics 
Committee advised that the study was exempt from NHS ethical review. 
 
  
Results 
Demographics 
Staff at 26 of the 51 pharmacies visited took part, with staff at the remaining 25 
declining due to either lack of time or staff shortages on the day. In the 26 pharmacies, 
136 team members who were on duty at the time of the visit participated (median 4, 
range 1-10 per pharmacy). The participants’ personal and practice demographics are 
provided in Table 1. Almost half worked in large multiple pharmacies (47.1%, 64), were 
pharmacists, pre-registration pharmacists or registered technicians (46.3%, 53), and 
were 30 years of age or under (44.9%, 61). The majority (88.2%, 120) were female, 
and two thirds (63.9%, 87) had been in their current position for five years or less. One 
quarter (25.0%, 34) had personal life experience of MCAs being provided to family 
members or friends.  
 
 <INSERT TABLE 1 HERE> 
 
Current activities in the provision of MCAs 
Participants’ responses to the list of activities involved in the provision of MCAs are given 
in Table 2. While pharmacists were involved largely in clinical and dispensing accuracy 
checking and liaising with others, almost two thirds (59.1%, 26) were involved in 
dispensing. All community pharmacy team positions, other than the three delivery 
drivers, had involvement in most activities. Within the same pharmacy, several different 
staff positions were commonly involved in the same activity.  
  
<INSERT TABLE 2 HERE> 
 
Table 3 gives the participant responses to who they felt ideally should perform these 
specific activities. Almost all (91.2%, 124) viewed that dispensing should be the remit of 
dispensing assistants while pharmacists should focus on assessment of patient suitability 
for MCA (98.5%, 134), clinical and final accuracy checking and monitoring patient 
benefit (83.8%, 114).  
 
<INSERT TABLE 3 HERE> 
 
Given that the delivery drivers’ involvement centred on delivery, their responses were 
excluded from further analysis.  
 
Potential influences on these activities 
When TDF determinants of behavior related items were subjected to PCA, the correlation 
matrix contained multiple coefficients above 0.3. The Kaiser–Meyer–Olkin measure of 
sampling adequacy (0.802) and Bartlett’s test of sphericity (significance <0.001) 
confirmed the factorability of the items. Seven components had Eigenvalues exceeding 
1.0, with the seven-component solution explaining 64.0% of the variance. These 
components all had high internal reliability; median, IQR and results of inferential 
analysis were as follows (see Table 4): 
 
<INSERT TABLE 4 HERE> 
 
i. Component 1, perceived knowledge of MCA related guidance and ease of application 
of guidance (7 items loaded, Cronbach’s alpha 0.931) 
The median total component score indicated overall neutral responses at a value of 19 
(IQR 8-24.5) on a scale of 7-35 (midpoint 21), with 35 representing the most positive 
responses, i.e. the highest level of agreement around knowledge. Responses to 
individual items indicated that while respondents viewed themselves as knowledgeable 
about several key documents, they felt that they these less easy to apply in practice. 
Around one third were unsure or disagreed (29.2%, 33) that they knew enough about 
the stability of medicines in MCAs. Pharmacists scored statistically significantly higher 
for this component than non-pharmacists (p<0.001). 
ii. Component 2, beliefs of capabilities relating to competence and confidence in MCA 
activities, and training (5 items loaded, Cronbach’s alpha 0.899) 
The median total component score indicated overall positive responses at a value of 21 
(IQR 19.5-24) on a scale of 5-25 (midpoint 15), with 25 representing the most positive 
responses i.e. the highest level of agreement with beliefs of consequences. There was 
overwhelming agreement with statements relating to competence, confidence, training 
and skills. Those working in small independent pharmacies scored statistically 
significantly higher for this component than those in other pharmacy types (p=0.003). 
iii. Component 3, issues of the appropriate working environment in terms of sufficient 
capacity, time, space, no undue stress or anxiety context  (7 items loaded, 
Cronbach’s alpha 0.772) 
The median total component score indicated overall neutral responses at a value of 21 
(IQR 18-24) on a scale of 7-35 (midpoint 21), with 35 representing the most positive 
responses, i.e. the highest level of agreement of appropriateness. There were particular 
concerns over the impact of exceeding pharmacy capacity to supply MCAs (69.2% 
agreement, 92), space issues (46.6%, 62). Just under one half were distracted by 
other staff (42.7%, 56) and one third felt that they did not have enough time for MCA 
activities (31.1%, 40). Those working in small independent pharmacies scored 
statistically significantly higher for this component than those in other pharmacy types 
(p<0.001) while pharmacists scored statistically significantly lower than non-
pharmacists (p=0.014). 
iv. Component 4, others expecting me to provide MCAs (3 items loaded, Cronbach’s 
alpha 0.603) 
The median total component score indicated overall negative responses at a value of 5 
(IQR 4-6) on a scale of 3-15 (midpoint 9), with 15 representing the most positive 
responses, i.e. that there were high levels of expectation to provide MCAs. Almost all 
felt that there were expectations to supply MCAs from patients and their families 
(97.7%, 121 agreement), GPs (93.1%, 121) and carers (85.8%, 107). Those with 
more years of experience scored statistically significantly higher for this component 
than those with less experience (p=0.016) as did those with personal experience of 
MCAs (p=0.003). 
v. Component 5, perceived knowledge of MCA patient assessment, decision to 
commence, and review (5 items loaded Cronbach’s alpha 0.724) 
The Median total component score indicated overall neutral responses at a value of 14 
(IQR 10-17.5) on a scale of 5-25 (midpoint 15), with 25 representing the most positive 
responses. i.e. the highest level of agreement around knowledge. There was a general 
lack of awareness on how patients were assessed prior to commencing an MCA 
(46.2%, 56 unsure or disagreeing), knowing enough to be able to assess patient need 
(54.0%, 61) or ability to use an MCA (53.6%, 60) or how patients were monitored 
(68.1%, 83). Pharmacists scored statistically significantly higher for this component 
than non-pharmacists (p=0.005). 
vi. Component 6, encouragement and incentives to provide MCAs (3 items loaded, 
Cronbach’s alpha 0.779) 
The median total component score indicated overall neutral responses at a value of 9 
(IQR 8-10) on a scale of 3-15 (midpoint 9), with 15 representing the most positive 
responses i.e. a high level of agreement around encouragement and incentives. While 
respondents were encouraged to provide MCAs, there was marked disagreement that 
their employers provided any incentives (87.5%, 110 unsure, disagreed). Pharmacists 
scored statistically significantly higher for this component than non-pharmacists 
(p=0.036). 
vii. Component 7, beliefs of consequences of MCAs leading to more effective and safer 
medicine use by patients (2 items loaded, Cronbach’s alpha 0.90) 
The median total component score indicated overall positive responses at a value of 8 
(IQR 7-8) on a scale of 2-10 (midpoint 6), with 10 representing the most positive 
responses i.e. a high level of agreement around beliefs of consequences. Three quarters 
respondents agreed that MCAs led to more effective (78.9%, 105) or safer (73.5%, 98) 
medicines use by patients. There were no statistically significant differences for this 
component between demographic groups.  
 
Reports of patient experiences 
Content analysis of responses to the open item on examples of patients who had 
benefitted as a result of MCAs generated themes of promoting adherence, independence, 
reducing stress and the ability to monitor patient progress. For anonymised examples of 
patients where MCAs had been unsuccessful, the themes were the lack of shared 
decision making, poorer adherence, medicines waste, additional medicines supplied 
outwith the MCA, complexities of changing medicines and pressure from others. Other 
comments on MCAs generally were principally around MCAs not always being the most 
appropriate solution. Themes and illustrative quotes are detailed in Table 5.  
 
<INSERT TABLE 5 HERE> 
 
  
Discussion 
One key finding of this study is that all community pharmacy team members were 
involved in some aspect of MCA provision and within the same pharmacy, several 
different staff positions were commonly involved in the same activity. There was similar 
diversity of opinion over the ideal staff member (or other) to perform specific MCA 
activities. PCA of the TDF determinants of behavior gave seven components of: 
perceived knowledge of MCA related guidance and ease of application of guidance; 
beliefs of capabilities relating to competence and confidence in MCA activities, and 
training; issues of the appropriate working environment in terms of sufficient capacity, 
time, space, no undue stress or anxiety; others expecting me to provide MCAs; 
perceived knowledge of MCA patient assessment, decision to commence, and review; 
encouragement and incentives to provide MCAs; and beliefs of consequences of MCAs 
leading to more effective and safer medicine use by patients.. The scores for others 
expecting me to provide MCAs were lowest, indicating that the participants  agreed that 
GPs, patients and their families, and carers expected them to provide MCAs. In response 
to open questions, many positive experiences of MCA provision were cited, with themes 
of promoting patient adherence and independence, reducing patient stress and 
enhancing patient monitoring. There were, however, many negative experiences, with 
themes of the lack of shared patient decision making, worsening adherence and 
generation of medicines waste, the issue of dealing with changing medicines and 
pressure from others. MCAs were not always considered to be the most appropriate 
solution.  
There are several strengths to this research. This is the first published study which has 
focused on the perspectives of the entire community pharmacy team. The items on 
influences on behavior were derived from psychological theory,13,14 increasing the likely 
construct and criterion validity.19 PCA analysis confirmed the factorability of the items, 
which clustered into seven components with high internal reliability. There are, however, 
several limitations to the study hence the findings should be interpreted with caution. 
Just under half of the pharmacies in the target area were unable to participate due to 
lack of time or staff shortages. While this may introduce a response bias, the 
participating community pharmacies were largely representative of all pharmacies in the 
area. Furthermore, the study was conducted in one city in the north east of Scotland 
hence the results may lack external validity. It is also possible that the findings may be 
skewed by those pharmacies with greater numbers of staff participants. However, it is 
likely that the key findings may resonate widely given the acknowledged global issues of 
polypharmacy, medicines non-adherence and the widespread use of MCAs.20-22 While it is 
recommended for PCA that the ratio of responses to items is 5:1,16 we achieved a ratio 
of 4.25:1 which may have reduced slightly the robustness of the analysis. In addition, 
the use of PCA rather than other factor analysis techniques such maximum likelihood 
exploratory factor analysis may have reduced the generalizability of the findings.  
Community pharmacy provision of MCAs involved all members of the pharmacy team 
and while the responses will depend on the actual staff and numbers employed within 
each pharmacy (e.g. not all pharmacies will have pre-registration pharmacists or 
accredited checking technicians) and their perceived roles, there may be a lack of a 
systematic approach to staff allocation to specific tasks. Notably, within the same 
pharmacy, several different staff positions were commonly involved in the same activity. 
While the policy direction of the Scottish Government is encouraging pharmacists to 
assume more clinical roles,23 almost two thirds of pharmacists were highly involved in 
MCA dispensing. Importantly less than one fifth of participants viewed that pharmacists 
were the ideal individuals to be dispensing MCAs, with this task being assigned to other 
members of the pharmacy workforce. The Scottish Government strategy, ‘Prescription 
for Excellence, A Vision and Action Plan for the right pharmaceutical care through 
integrated partnerships and innovation’,23 published in 2013, articulates the strategic 
direction for pharmacy practice over the next decade. It outlines that pharmacists 
providing pharmaceutical care will be accredited clinical pharmacist independent 
prescribers working in partnership with the wider health and social care team. There is 
therefore opportunity to shift the pharmacist focus in MCA provision from dispensing to 
review of medicines. The need for clinical review of medicines was highlighted recently 
by Counter et al. who, in the same geographical setting, identified high prevalence of 
potentially inappropriate medicines in patients provided MCAs.10 The results from our 
study relating to task allocation and ideal task allocation indicate the need for a more 
systematic approach within the community pharmacy, which should also involve more 
clearly defined communication channels with the patient, other members of the health 
and social care team, carers and family members.    
The results of the PCA analysis, with behavioral influences clustering into seven 
components, also highlight several key issues. The lowest scores were in relation to 
others expecting me to provide MCAs, with highlighting the expectations of GPs, patients 
and family members, and carers that pharmacies would provide MCAs. Interestingly, 
those participants who had personal life experience of MCAs and greater work experience 
were statistically significantly less likely to agree with these expectations. While 
expectation does not necessarily equate to any concern, pressure from others did 
emerge as a key theme in relation to challenges of providing MCAs. This issue was also 
highlighted by MacLure et al. who found that GPs in particular were unaware of capacity 
issues in community pharmacy.6  
Scores for the components of perceived knowledge of MCA related guidance and ease of 
application of guidance, issues of the appropriate working environment in terms of 
sufficient capacity, time, space, no undue stress or anxiety, perceived knowledge of MCA 
patient assessment, decision to commence, and review and encouragement and 
incentives to provide MCAs were more neutral. For perceived knowledge, there were 
issues around the application of various guidance documents to practice hence the need 
for practitioner engagement at all stages of guidance development and implementation. 
There were also issues around medicines stability, which can lead to some medicines 
being supplied outwith the MCA, as shown in previous research.10 This adds to the 
complexities of medicines storage and medicines taking, with possible consequences of 
patient confusion and non-adherence. These consequences were also generated as 
themes around unsuccessful provision of MCAs. Other studies have also noted the 
potential for confusion and error when medicines are altered part way through the MCA 
cycle, with clear implications for patient care and safety.6,11,12   
While the scores for the component of issues the appropriate working environment in 
terms of sufficient capacity, time, space, no undue stress or anxiety were neutral, 
pharmacists tended to score lower than others, perhaps reflecting their supervisory and 
management focus. Participants voiced particular concerns over pharmacy capacity to 
supply MCAs, insufficient space for filling MCAs and workload distraction. This may have 
led to almost all participants stating that they prepared four weeks of MCA supplies at 
one time, which is contrary to the guidance of the RPS,1 and may exacerbate 
complexities of medicines altering mid MCA cycle. These issues may lead to less safe 
working conditions which could compromise patient care and safety.  
In terms of the component of perceived knowledge of MCA patient assessment, decision 
to commence, and review, there was less agreement around aspects such as knowing 
enough about the patient to conduct assessment of the need for and ability to use an 
MCA. Despite pharmacists scoring higher than other staff members, there is a clear lack 
of clarity around these processes. Similarly, pharmacists scored significantly higher for 
the component of encouragement and incentives to provide MCAs  from their employers 
and the NHS but noted that there were no related incentives. Encouragingly, the scores 
for the component of beliefs of capabilities relating to competence and confidence in MCA 
activities, and training  were generally high in terms of competence, confidence, training 
and skills, as were the scores for of MCAs leading to more effective and safer medicine 
use by patients. There was overwhelming agreement that MCAs could lead to more 
effective and safer medicines use.  
The findings of this research are important for patient care and professional practice in 
any setting or country involved in MCA provision. Patient non-adherence to prescribed 
medicines is an acknowledged global issue with non-adherence estimated to be 
prevalent in 47% to 100% of older people.22 Promoting adherence, fostering 
independence and reducing patient and carer stress were identified as key themes 
around participants’ experiences of successful use of MCAs, as has been reported by 
others.4-6 However, non-adherence is known to be complex, multifactorial,22,24 and 
cannot easily solved simply by provision of an MCA. Participants cited examples of the 
lack of patient involvement in the decision to commence an MCA and the potential 
impact of poorer adherence. The theme of MCAs not necessarily being the solution 
emerged strongly, highlighting the need for a well-defined patient pathway around all 
aspects of MCA provision. This should include the processes of: identification of 
individuals who may benefit from an MCA; review of the medicines; assessment of 
capability to use an MCA; issues relating to supply; and review of benefit. A feasibility 
and pilot study comparing the effectiveness and cost-effectiveness of MCAs compared to 
standard care has been reported recently. The authors concluded that a fully powered 
RCT is warranted,3 the results of which could inform a well-defined pathway.  
Future research should focus on developing, implementing and evaluating an 
intervention around the pharmacy provision of MCAs encompassing all processes. Within 
community pharmacy, there is a clear need to define the roles and remit of different 
members of the team, how these relate to each other, the patient, other members of the 
health and social care team, family members and carers. 
In conclusion, this research has identified that while community pharmacy teams value 
MCAs in terms of positive impact on effective and safe medicines use by patients, there 
are key issues around staff assignment to particular roles and how these relate to other 
roles and tasks. Notably, within the same pharmacy, several different staff positions 
were commonly involved in the same activity. Pharmacists were highly involved in MCA 
dispensing, with less involvement in more clinically focused activities. Participants 
viewed themselves as competent, confident and trained for their roles. There were key 
issues around GPs, patients and their families, and carers expecting community 
pharmacies to provide MCAs without due regard to capacity. There were also concerns 
around a lack of shared decision making, MCAs worsening medicines adherence, 
generating medicines waste, and the issue of dealing with changing medicines. MCAs 
were not always considered to be the most appropriate solution. 
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Table 1 - Respondent personal and practice demographics (N=136) 
Demographic % (n) 
Position 
    Pharmacist 
    Pre-registration pharmacist 
    Registered technician (accredited checking) 
    Registered technician 
    Dispensing assistant 
    Medicines counter assistant 
    Delivery driver 
 
32.3 (44) 
7.4 (10) 
3.7 (5) 
2.9 (4) 
36.0 (49) 
15.4 (21) 
2.2 (3) 
Age (years) 
    <20  
    21-30 
    31-40 
    41-50 
    51-60 
    >60 
 
5.9 (8) 
39.0 (53) 
16.9 (23) 
17.6 (24) 
14.7 (20) 
5.9 (8) 
Sex 
    Female 
    Male 
 
88.2 (120) 
11.8 (16) 
Number of years in current position 
    ≤1 
    2-5 
    6-9 
    ≥10 
 
33.8 (46) 
30.1 (41) 
8.1 (11) 
27.9 (38) 
Personal life experience of MCAs (e.g. family, friends)  
    Yes 
    No 
 
25.0 (34) 
75.0 (102) 
Pharmacy type 
    Small independent (1-4 pharmacies) 
    Small multiple (5-30) 
    Large Multiple (>30)     
 
32.4 (44) 
20.6 (28) 
47.1 (64)  
  
Table 2 – Percentage and number of participants who reported undertaking the activities listed related to 
the provision of MCAs,  
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Dispensing 59.1 
(26) 
 
90.0 
(9) 
80.0 
(4) 
100.0 
(4) 
100.0 
(49) 
23.8 
(5) 
0 
Completion of documentation  84.1 
(37) 
 
90.0 
(9) 
100.0 
(5) 
100.0 
(4) 
79.6 
(39) 
33.3 
(7) 
33.3 
(1) 
Assessment of patient suitability 75.0    
(33) 
 
80.0 
(8) 
80.0 
(4) 
50.0 
(2) 
18.4 
(9) 
4.8   
(1) 
0 
Clinical checking of prescription  97.7 
(43) 
 
20.0 
(2) 
20.0  
(1) 
25.0 
(1) 
14.3 
(7) 
0 0 
Final accuracy check of MCA 100.0 
(44) 
 
10.0 
(1) 
80.0 
(4) 
50.0 
(2) 
6.1  
(3) 
4.8  
(1) 
0 
Handing to patients/ 
representatives  
84.1 
(37) 
 
100.0 
(10) 
100.0 
(5) 
100.0 
(4) 
42.9 
(21) 
95.2 
(20) 
100.0 
(3)  
Delivery to patients’ homes 15.9 
(7) 
 
40.0 
(4) 
20.0 
(1) 
25.0 
(1) 
34.7 
(17) 
42.9 
(9) 
100.0 
(3) 
Collection of obsolete MCAs  15.9 
(7) 
 
60.0 
(6) 
40.0 
(2) 
50.0 
(2) 
38.8 
(19) 
38.1 
(8) 
66.7 
(2) 
Liaising with GP surgery – 
ordering 
86.4 
(38) 
80.0 
(8) 
100.0 
(5) 
100.0 
(4) 
85.7 
(42) 
9.5  
(2) 
33.3 
(1) 
 
Liaising with GP surgery – 
queries 
97.7 
(43) 
80.0 
(8) 
100.0 
(5) 
100.0 
(4) 
95.9 
(47) 
9.5  
(2) 
33.3 
(1) 
 
Liaising with patients/ 
representatives 
100.0 
(44) 
 
90.0 
(9) 
100.0 
(5) 
100.0 
(4) 
91.8 
(45) 
52.4 
(11) 
100.0 
(3) 
Monitoring benefit of MCA to 
patient 
68.2 
(30) 
 
50.0 
(5) 
80.0 
(4) 
25.0 
(1) 
36.7 
(18) 
19.0 
(4) 
33.3 
(1) 
Table 3 – Percentage and number of participants reporting who ideally should perform specific activities 
relating to MCA provision (N=136; participants could name more than one hence totals may exceed 
100%)  
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Dispensing 19.9 
(27) 
14.0  
(19) 
8.1 
(11) 
15.4 
(21) 
91.2  
(124) 
0.7 
(1) 
 
Family 0.7 (1) 
Completion of documentation  55.1 
(75) 
 
22.1 
(30) 
16.2 
(22) 
14.7 
(20) 
81.6 
(111) 
1.5 
(2) 
0 
Assessment of patient suitability 98.5 
(134) 
9.6  
(13) 
6.6  
(9) 
2.9 
(4) 
12.5  
(17) 
0 Doctor 24.3 (33) 
Nurse 13.2 (18) 
Social worker 9.6  
(13) 
Carer 3.7 (5) 
Family 0.7 (1) 
Clinical checking of prescription  100 
(136) 
4.4 
(6) 
4.4 
(6) 
2.9 
(4) 
8.1 
(11) 
1.5 
(2) 
Doctor 2.2 (3) 
Final accuracy check of MCA 90.4 
(123) 
1.5 
(2) 
 
32.4 
(44) 
1.5 
(2) 
1 
(0.7) 
 
0 0 
Handing to patients/ 
representatives  
79.4 
(108) 
24.3  
(33) 
21.3 
(29) 
21.3 
(29) 
83.8 
(114) 
72.1 
(98) 
 
Delivery driver 11.8 
(16) 
Delivery to patients’ homes 3.7 
(5) 
 
0 0 0 11.0 
(15) 
14.7 
(20) 
Delivery driver 75.7 
(103) 
Collection of obsolete MCAs  12.5  
(17) 
 
4.4 
(6) 
2.2 
(3) 
5.9 
(8) 
20.6 
(28) 
11.8 
(16) 
Patient 5.9 (8) 
Carer 2.9 (4) 
Nurse 1.5 (2) 
Family 0.7 (1) 
Social worker 0.7 
(1) 
Liaising with GP surgery – 
ordering 
65.4 
(89) 
20.6 
(28) 
 
17.6 
(24) 
13.2 
(18) 
78.7 
(107) 
4.4 
(6) 
Delivery driver 0.7 
(1) 
Liaising with GP surgery – 
queries 
89.7 
(122) 
23.5 
(32) 
20.6 
(28) 
8.8 
(12) 
62.5 
(85) 
 
2.2  
(3) 
Delivery driver 0.7 
(1) 
Liaising with patients/ 
representatives 
91.1 
(124) 
26.5 
(36) 
20.6 
(28) 
 
13.2 
(18) 
67.6 
(92) 
24.3  
(33) 
Doctor 1.5 (2) 
Delivery driver 2.9 
(4) 
Monitoring benefit of MCA to 
patient 
83.8 
(114) 
 
14.7 
(20) 
9.6  
(13) 
4.4 
(6) 
24.3  
(33) 
3.7 
(5) 
Doctor 18.4 (25) 
Nurse 8.1 (11) 
Social worker 6.6  
(9) 
Delivery driver 4.4 
(6) 
Carer 3.7 (5) 
Family 0.7 (1) 
Table 4 - Participant responses to TDF behavioral determinant statements  
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Component 1, perceived knowledge of MCA related guidance and ease of application of guidance  
Cronbach’s alpha, 0.931 
Median total component score = 19 (IQR 8-24.5) on a scale of 7-35 (midpoint 21), with 35 representing the most positive responses.  
I know enough about the RPS professional guidance on the supply of MCAs (n=108) 8.3 
(9) 
47.2 
(51) 
11.1 
(12) 
27.8 
(30) 
5.6 
(6) 
I find the RPS professional guidance on the provision of MCAs easy to apply in practice (n=77) 2.6 
(2) 
51.9 
(40) 
37.7 
(29) 
7.6 
(6) 
0 
I know enough about the United Kingdom Medicines Information (UKMi) Medicines Compliance Aid Database 
(n=105) 
2.9 
(3) 
27.6 
(29) 
13.3 
(14) 
44.8 
(47) 
11.4 
(12) 
I find the UKMi guidance on medicine suitability easy to apply in practice (n=76) 3.9 
(3) 
50.0 
(38) 
34.2 
(26) 
11.8 
(9) 
0 
I know enough about the Grampian Service Level Agreement on the supply of MCAs (n=106) 8.5 
(9) 
41.5 
(44) 
16.0 
(17) 
26.4 
(28) 
7.5 
(8) 
I find the Grampian Service Level Agreement on provision of MCAs easy to apply in practice (n=81) 3.7 
(3) 
45.7 
(37) 
29.6 
(24) 
18.5 
(15) 
2.5 
(2) 
I know enough about the stability of medicines in MCAs (n=113) 8.0 
(9) 
62.8 
(71) 
8.8 
(10) 
18.6 
(21) 
1.8 
(2) 
Component 2, beliefs of capabilities relating to competence and confidence in MCA activities, and training  
Cronbach’s alpha, 0.889 
Median total component score = 21 (IQR 19.5-24) on a scale of 5-25 (midpoint 15), with 25 representing the most positive responses.  
I feel competent in my role with MCAs (n=133) 38.3 
(51) 
54.9 
(73) 
5.3 
(7) 
1.5 
(2) 
0 
I feel confident in my role with MCAs (n=133) 37.6 
(50) 
53.4 
(71) 
6.8 
(9) 
2.3 
(3) 
0 
I feel that I have the skills to do what I do in relation to MCAs (n=133) 38.3 
(51) 
57.1 
(76) 
3.6 
(5) 
0.8 
(1) 
0 
I have been trained for my role in provision of MCAs (n=133) 28.6 
(38) 
51.1 
(68) 
10.5 
(14) 
9.8 
(13) 
0 
In relation to provision of MCAs, we decided it was better use of our time to make up 4 weeks’ supply of each 
MCA at once (n=129) 
49.6 
(64) 
42.6 
(55) 
4.7 
(6) 
1.6 
(2) 
1.6 
(2) 
Component 3, issues of the appropriate working environment in terms of sufficient capacity, time, space, no undue stress or anxiety 
Cronbach’s alpha, 0.772 
Median total component score = 21 (IQR 18-24) on a scale of 7-35 (midpoint 21), with 35 representing the most positive responses.  
* items reverse scored 
*When dealing with MCAs, I feel stressed (n=133) 3.6 
(5) 
24.1 
(32) 
11.3 
(15) 
56.4 
(75) 
4.5 
(6) 
*I am concerned about the effect on my pharmacy team if we exceed our capacity to supply MCAs (n=133) 22.6 
(30) 
46.6 
(62) 
9.8 
(13) 
21.1 
(28) 
0 
*In relation to provision of MCAs, I don’t have enough time for my current role (n=129) 6.2 
(8) 
24.8 
(32) 
9.3 
(12) 
53.5 
(69) 
6.2 
(8) 
In relation to provision of MCAs, there are enough competent staff in the pharmacy (n=133) 16.5 
(22) 
57.1 
(76) 
6.8 
(9) 
18.0 
(24) 
1.5 
(2) 
*When dealing with MCAs, I feel anxious (n=133) 3.0 
(4) 
7.5 
(10) 
5.3 
(7) 
67.7 
(90) 
16.5 
(22) 
*In relation to provision of MCAs, other staff sometimes distract me when I am working (n=131) 12.2 
(16) 
30.5 
(40) 
8.4 
(11) 
42.3 
(58) 
4.6 
(6) 
*In relation to provision of MCAs, there is insufficient space in the pharmacy for our level of  activity (n=133) 15.8 
(21) 
30.8 
(41) 
9.0 
(12) 
42.1 
(56) 
2.3 
(3) 
Component 4, others expecting me to provide MCAs  
Cronbach’s alpha, 0.603 
Median total component score = 5 (IQR 4-6) on a scale of 3-15 (midpoint 9), with 15 representing the most positive responses.  
* items reverse scored 
*GP practices expect me to provide MCAs (n=130) 36.9 
(48) 
56.2 
(73) 
6.2 
(8) 
0.8 
(1) 
0 
*Patients and their families expect me to provide MCAs (n=129) 41.1 
(53) 
56.6 
(73) 
0.8 
(1) 
1.6 
(2) 
0 
*Carers expect me to provide MCAs (n=127) 32.3 
(41) 
53.5 
(68) 
7.1 
(9) 
7.1 
(9) 
0 
Component 5, perceived knowledge of MCA patient assessment, decision to commence, and review 
Cronbach’s alpha, 0.724 
Median total component score = 14 (IQR 10-17.5) on a scale of 5-25 (midpoint 15), with 25 representing the most positive responses. * items 
reverse scored 
I know enough about how patients on MCAs are monitored to see if they’re helping (n=122) 6.6 
(8) 
33.6 
(41) 
20.5 
(25) 
36.1 
(44) 
11.5 
(14) 
I know enough about the patient to be able to assess their need for an MCA (n=113) 6.0 
(8) 
38.9 
(44) 
24.8 
(28) 
24.8 
(28) 
4.4 
(5) 
I know enough about the patient to be able to assess their ability to use an MCA (n=112) 4.5 
(5) 
42.0 
(47) 
27.7 
(31) 
23.2 
(26) 
2.7 
(3) 
  
I know enough about how patients are assessed prior to the decision to start and MCA (n=121) 11.6 
(14) 
42.1 
(51) 
15.7 
(19) 
26.4 
(32) 
4.1 
(5) 
*I sometimes find it difficult to decide whether a patient should get an MCA (n=93) 1.1 
(1) 
45.2 
(42) 
18.3 
(17) 
32.3 
(30) 
3.2 
(3) 
Component 6, encouragement and incentives to provide MCAst 
Cronbach’s alpha, 0.779 
Median total component score = 9 (IQR 8-10) on a scale of 3-15 (midpoint 9), with 15 representing the most positive responses.  
My employer encourages me to provide MCAs (n=127) 22.0 
(28) 
44.9 
(57) 
20.5 
(26) 
11.0 
(14) 
1.6 
(2) 
My employer creates incentives for me to provide MCAs (n=126) 1.6 
(2) 
11.1 
(14) 
9.5 
(12) 
59.5 
(75) 
18.3 
(23) 
NHS Grampian encourages me to provide MCAs (n=122) 9.0 
(11) 
23.0 
(28) 
45.1 
(55) 
22.1 
(27) 
0.8 
(1) 
Component 7, beliefs of consequences of MCAs leading to more effective and safer medicine use by patients 
Cronbach’s alpha, 0.90 
Median total component score = 8 (IQR 7-8) on a scale of 2-10 (midpoint 6), with 10 representing the most positive responses.  
I believe that MCAs lead to more effective medicine use by the patient (n=133) 15.0 
(20) 
63.9 
(85) 
18.8 
(25) 
2.3 
(3) 
0 
I believe that MCAs lead to safer medicine use by the patient (n=133) 15.8 
(21) 
57.9 
(77) 
22.6 
(30) 
3.8 
(5) 
0 
Table 5 – Themes and illustrative quotes comments relating to positive and negative examples of 
MCA use 
Positive examples 
Themes Illustrative quotes 
Promoting adherence ‘Elderly polypharmacy patient who was on over ten medicines and 
was very confused therefore not complying with her medication. 
The use of an MCA meant her medicines were already organised 
for her so she took them correctly without hesitation.’ 
 
‘Epileptic patient with memory issues was uncontrolled on 
medication and had no structure to their medication regimen. Put 
on MCA and it helped greatly to control their illness, improved 
their quality of life.’ 
 
‘Lady who was uncertain of the doses she was to be taking and 
overdosed on zopiclone several times. MCA took this responsibility 
of remembering out of her hands.’ 
Independence ‘Patient whose daughter was the primary carer. Her daughter then 
moved away with her husband’s work and lady was unable to 
manage medications herself. Pharmacy suggested MCA, she is now 
able to manage her medications independently.’ 
Reducing stress ‘25 year old male. His mother cares for him and collects his 
medicines. She is often very stressed so by using the MCA it helps 
her by taking a lot of pressure off her.’ 
Ability to monitor patient 
progress 
‘Lady was running out of her medicines all the time. Decided to 
give her a weekly supply in an MCA. Pharmacy staff ensure that 
she brings back her MCA every week before she can get her next 
week’s supply.’ 
Negative examples 
Themes Illustrative quotes 
Lack of shared decision 
making 
‘GP requested an MCA without the patient’s input. Patient wasn’t 
happy, didn’t feel like they needed MCA.’ 
 
‘Lady who refused to use it as she felt she had lost control over 
her own medication.’ 
Poorer adherence ‘Elderly patient who is confused by how the MCA works therefore 
refuses to use it which has led to them being more confused as 
they are not taking any medication at all.’ 
 
‘Patient who gets medication delivered weekly would open up MCA 
and tip out all of the medication in the box, picked what she 
wanted and put it in a bowl.’ 
Medicines waste ‘Lots of MCAs are returned to pharmacy untouched due to poor 
patient compliance.’ 
 
‘Patient’s daughter complained that there were 20 Dosettes piling 
up in her house unused and the pharmacy was still delivering 
them. Nobody had told the pharmacy that the patient wasn’t using 
the medication.’ 
Medicines supplied outwith 
the MCA 
‘Confusing when medicines are given alongside MCA. Patients on 
warfarin [outwith the MCA] are focusing on MCA instead of their 
warfarin.’ 
Complexities of changing 
medicines 
‘Medicines changed mid-cycle. If patients and carers are aware 
that it needs to be changed straight away, GP should involve 
pharmacy as patients could still be taking the wrong medication.’ 
Pressure from others ‘GP surgery said a patient needed an MCA straight away. There 
was pressure on the pharmacy to supply him with an MCA. Patient 
had not been properly assessed and as a result took his medicines 
incorrectly.’ 
Comments on MCAs generally 
Theme Illustrative comments 
MCAs not always the 
solution 
‘Families, carers and social workers seem to think that MCAs are a 
magic answer. However, they are not the answer for everyone.’ 
 
‘Doctors often think that an MCA is the solution to patients’ 
problems, however, often more formal care is needed.’ 
 
‘MCAs are only effective if they are for the right patient. So, ‘Does 
the patient need it?’ needs to be considered more. More initial 
follow-ups need to be carried out. More monitoring and 
assessment of patient ability to use an MCA needs to be thought 
about more often.’ 
 
